Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Abbisko Therapeutics
Explore 18 clinical trials worldwide
Search
Showing 1-18 of 18 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Abbisko Therapeutics
Clinical Trials (18)
NCT07010497
A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
PHASE2
Not yet recruiting
33 participants
Started: Nov 14, 2025 · Completed: Mar 31, 2029
1 condition
2 sponsors
1 location
NCT07164170
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
PHASE2
Not yet recruiting
86 participants
Started: Oct 25, 2025 · Completed: Jul 30, 2029
1 condition
1 sponsor
17 locations
NCT07210996
A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects
PHASE1
Active, not recruiting
20 participants
Started: Sep 12, 2025 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT07007546
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants
PHASE1
Recruiting
42 participants
Started: May 17, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06884072
A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy Subjects
PHASE1
Active, not recruiting
16 participants
Started: Apr 8, 2025 · Completed: Aug 1, 2025
1 condition
1 sponsor
1 location
NCT06896760
A Mass Balance Study of [14C]ABSK011
PHASE1
Not yet recruiting
6 participants
Started: Apr 7, 2025 · Completed: Apr 7, 2026
1 condition
1 sponsor
1 location
NCT06668103
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
PHASE2
Recruiting
54 participants
Started: Nov 25, 2024 · Completed: Jun 30, 2028
1 condition
1 sponsor
5 locations
NCT06632262
A Phase 2 Clinical Study of ABSK061 and ABSK043
PHASE2
Recruiting
202 participants
Started: Nov 13, 2024 · Completed: Jun 30, 2030
4 conditions
1 sponsor
21 locations
NCT06306872
A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules
PHASE1
Recruiting
73 participants
Started: Feb 23, 2024 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06225804
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
PHASE1
Recruiting
164 participants
Started: Feb 22, 2024 · Completed: Mar 31, 2028
1 condition
1 sponsor
14 locations
NCT06111274
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
PHASE2
Recruiting
82 participants
Started: Oct 17, 2023 · Completed: Dec 29, 2026
1 condition
1 sponsor
5 locations
NCT05627063
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
169 participants
Started: Jun 26, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
24 locations
NCT06186804
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
PHASE2
Enrolling by invitation
64 participants
Started: May 30, 2023 · Completed: Dec 30, 2026
1 condition
1 sponsor
14 locations
NCT05804045
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
PHASE3
Active, not recruiting
90 participants
Started: Apr 27, 2023 · Completed: Jun 30, 2028
3 conditions
1 sponsor
40 locations
NCT05775874
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
PHASE2
Recruiting
80 participants
Started: Sep 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05244551
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
85 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
22 locations
NCT04906434
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
PHASE1
Recruiting
200 participants
Started: Feb 26, 2020 · Completed: Dec 31, 2028
1 condition
1 sponsor
32 locations
NCT04192344
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
PHASE1
Recruiting
276 participants
Started: Jan 20, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
17 locations